Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing reports final voting tallies for two proposals: (1) election of two Class I directors (Daniel Nelson and Hongfei Zhang, both elected with overwhelming support), and (2) ratification of Carr, Riggs & Ingram, L.L.C. as independent auditor (ratified with 27,782,849 votes for). This is a textbook Item 5.07 disclosure with specific vote counts and outcomes.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-17
Item 8.01
The disclosure announces a 1-for-20 reverse share split effective July 1, 2026, for the 2x Long VIX Futures ETF (UVIX). While reverse splits are structural corporate actions that affect share price and outstanding share count, this event does not fit neatly into the delisting_risk category (no delisting threat is mentioned) nor any other specific taxonomy category. The action is material to shareholders as it affects NAV per share, share count, and potential tax consequences from fractional share redemptions, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-17
Myseum.AI announced signing a non-binding letter of intent with Scanon.ai Systems to explore a collaborative development partnership involving integration of AI and computer vision capabilities into the Company's Picture Party platform, with potential reciprocal revenue sharing and participation in Scanon's financing round. While this represents a material strategic partnership announcement, it does not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control is disclosed—only a non-binding LOI for collaboration), nor does it constitute a standard earnings release, executive change, or other enumerated event type. The disclosure would affect a reasonable investor's assessment of the Company's strategic direction and product roadmap.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-17
EX-99.1
This news release discloses the voting results from Orla Mining's Annual General and Special Meeting of Shareholders held on June 16, 2026. It reports the election of all nine board nominees, the appointment of Deloitte LLP as auditor, and approval of a non-binding advisory resolution on executive compensation ("say-on-pay"), with detailed vote tallies for each item. This is a classic shareholder_vote_results disclosure under Item 5.07 of the 8-K taxonomy, adapted to a 6-K context.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-17
EX-99.1
This exhibit is a formal Report on Voting Results for Orla Mining's Annual General and Special Meeting of Shareholders held June 16, 2026, disclosing the outcomes of three shareholder votes: election of nine directors, appointment of Deloitte LLP as auditors, and a say-on-pay advisory resolution. All matters carried with substantial majorities. This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 and material to investors assessing governance and board composition.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-17
EX-99.1
Sun Life announces the offering of $750 million principal amount of Series 2026-1 Subordinated Unsecured 4.21% Fixed/Floating Debentures due 2038, with expected closing on June 19, 2026. This is a material creation of a new direct financial obligation (debt issuance) that would affect a reasonable investor's assessment of the company's capital structure and leverage. The proceeds are designated for general corporate purposes including investments in subsidiaries, repayment of indebtedness, and strategic investments, and are expected to qualify for Tier 2 capital.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-06-17
EX-99.1
The release announces the appointment of Josué Romanos as Vice President, Projects, effective immediately. While the exhibit also provides an operational update on the exploration adit at Guayabales, the principal disclosed action is the executive appointment. Romanos brings 30+ years of experience managing multi-billion-dollar capital projects, which is material to investors assessing the company's execution capability as it advances its flagship project.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-17
The 6-K discloses Board of Directors minutes approving a merger of Fibrasil Infraestrutura e Fibra Ótica S.A., a wholly owned subsidiary, into Telefônica Brasil. The Board approved the Merger Protocol, an independent appraisal valuing Fibrasil's equity at R$ 812.6 million, and authorized management to implement the merger effective August 1, 2026. This is a material acquisition/change of control transaction requiring shareholder approval at an Extraordinary General Meeting.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-17
The 6-K discloses minutes of Telefônica Brasil's Fiscal Council meeting approving a merger of Fibrasil Infraestrutura e Fibra Ótica S.A., a wholly owned subsidiary, into the Company. The Fiscal Council unanimously recommended approval by the Extraordinary General Meeting, with an effective date of August 1, 2026. This is a material acquisition/change of control transaction involving consolidation of a subsidiary, supported by an independent appraisal valuing Fibrasil's equity at R$ 812.6 million.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-17
The 6-K discloses minutes of the Audit and Control Committee meeting approving a merger of Fibrasil Infraestrutura e Fibra Ótica S.A., a wholly owned subsidiary, into Telefônica Brasil. The Committee unanimously recommended approval of the merger, which is expected to be submitted to the Board and then to an Extraordinary General Meeting of shareholders. The merger is material to the registrant's corporate structure and strategy, involving consolidation of telecommunications infrastructure assets and simplification of the corporate structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-17
The 6-K discloses a merger of Fibrasil Infraestrutura e Fibra Ótica S.A., a wholly-owned subsidiary, into Telefônica Brasil S.A., approved by the Board of Directors on June 16, 2026, with an extraordinary shareholders' meeting scheduled for July 31, 2026. Although Fibrasil is 100% owned by the Company (eliminating share-exchange considerations), the merger constitutes a material acquisition/change-of-control transaction under Item 1.01 of the 8-K taxonomy, involving consolidation of a subsidiary's assets (R$812.6 million in equity) and simplification of corporate structure—a strategic reorganization material to investors assessing the registrant's operational and financial position.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-06-17
This is a call notice for an Extraordinary Shareholders' Meeting scheduled for July 31, 2026, to vote on a material merger of Fibrasil Infraestrutura e Fibra Ótica S.A. into Telefônica Brasil. The primary agenda items include ratification of an appraiser, examination of an appraisal report, approval of a merger protocol, and authorization of the merger effective August 1, 2026. While technically a notice rather than results, the substance is a shareholder vote on a material M&A transaction that would materially affect the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Chegg's June 12, 2026 Annual Meeting of Stockholders. The filing presents detailed voting tallies for four proposals: election of three directors (Dan Rosensweig, Ted Schlein, and Renee Budig), advisory approval of named executive officer compensation, ratification of Grant Thornton LLP as auditor, and approval of a reverse stock split amendment. All proposals passed by required stockholder vote, making this a material disclosure of governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Citizens Community Bancorp's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing reports voting outcomes for four proposals: election of three directors (Michael Conner, Francis Felber, and Nicholas Amundsen), approval of the 2026 Omnibus Incentive Plan, advisory vote on named executive officer compensation, and ratification of Crowe LLP as independent auditor. All proposals passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-17
Item 7.01
The Board unanimously approved submitting governance proposals to stockholders to eliminate the classified board structure and all supermajority voting provisions in the Articles of Incorporation. This represents a material change to corporate governance structure that would affect shareholder voting rights and director election processes. While not fitting neatly into the specific event categories (it is not a shareholder vote result, but rather a proposal for one), the elimination of classified boards and supermajority voting provisions is material to investors' assessment of governance and control dynamics.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
Ardelyx held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on five proposals: election of three Class III directors (Robert Bazemore, Muna Bhanji, and Richard Rodgers), a Say-On-Pay advisory vote, a Say-On-Frequency advisory vote (annual), ratification of Ernst & Young LLP as independent auditor, and approval of the second amendment to the Amended and Restated 2014 Equity Incentive Award Plan. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Oak Valley Bancorp's Annual Meeting of Shareholders held June 16, 2026. Item 5.07 explicitly requires disclosure of voting results on matters submitted to security holders. The filing reports votes on two matters: (1) re-election of four board members (Christopher M. Courtney, Lynn R. Dickerson, Allison C. Lafferty, and Terrance P. Withrow), and (2) ratification of RSM US LLP as the independent auditor. Board elections and auditor ratification are material governance matters affecting investor confidence in the company's oversight and financial reporting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 11, 2026. The filing reports final vote tallies for all five proposals, including director elections, executive compensation advisory vote, stock plan approval, certificate amendment, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the detailed voting data with percentages and broker non-votes confirms this classification.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-17
Item 5.02
The filing discloses Compensation Committee approval of annual base salary adjustments for three named executives: Louis Hoch (CEO) at $995,000, Greg Carter (SVP, Chief Accounting Officer) at $325,000, and Michael White (SVP, Chief Accounting Officer) at $260,000, all effective August 3, 2026. This is a direct disclosure of compensatory arrangements under Item 5.02(e), which is material to investors assessing executive compensation practices.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
SeaStar Medical held its annual meeting of shareholders on June 17, 2026, with stockholders voting on four proposals: election of Class I director John Neuman, approval of an amended 2022 Omnibus Incentive Plan increasing authorized shares from 207,046 to 896,546, ratification of WithumSmith+Brown, PC as independent auditor, and adjournment authority. All four proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Neonode's 2026 Annual Meeting of Stockholders held on June 17, 2026, covering three proposals: election of directors (Peter Lindell and Per Löfgren), ratification of Crowe LLP as independent auditor, and an advisory say-on-pay vote. The filing presents voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-17
Item 1.01
AXT's subsidiary Tongmei entered into a long-term supply agreement with Casela committing Casela to purchase approximately $25.4 million of InP wafer substrates during 2027, with 50% prepayment required within 15 business days. While this is a material commercial contract (Item 1.01), it is fundamentally a supply/customer agreement rather than a merger, acquisition, disposition, or change of control. The agreement secures significant committed revenue and prepayment but does not fit the specific M&A taxonomy categories, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
Item 1.01
The Company amended pre-funded warrants originally issued in October 2025 to remove exercisability restrictions, enabling R01 Fund LP and Framework Ventures IV L.P. to exercise their warrants on a cashless basis, resulting in the issuance of an aggregate of 22,614,600 shares of Common Stock and increasing outstanding shares from approximately 27.8 million to 50.4 million shares.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
This Item 5.07 filing discloses the complete results of GeoVax Labs' annual stockholder meeting held on June 17, 2026, including voting outcomes on director elections, warrant exercise proposals, auditor ratification, and executive compensation advisory votes. The disclosure of shareholder voting results on material matters such as director elections and dilutive warrant issuances (totaling over 3.8 million shares) is material to investors assessing corporate governance and capital structure changes.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-17
Item 5.02
The disclosure centers on the Compensation Committee's approval of equity awards (1,961,986 PSUs and 783,618 RSUs) granted to executive officers including the CEO, CFO, and Chief Accounting Officer under the 2026 Equity Incentive Plan. This is a classic compensatory arrangement disclosure under Item 5.02(e), with specific vesting schedules and performance targets tied to stock price appreciation over three years. The awards represent 37% of authorized shares and are material to investor assessment of executive compensation.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-17
Item 8.01
The Company extended the expiration date of a rights offering from June 23 to June 29, 2026, at a subscription price of $6.90 per share. While this is a material capital-raising event affecting shareholder dilution and the Company's financing timeline, it does not fit neatly into the more specific categories (dilutive_issuance typically covers the initial announcement of an unregistered equity sale, not an extension of an existing offering). The extension itself is material to investors tracking the offering's progress and their subscription decision window.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-17
Item 7.01
The filing discloses a "strategic investment in Skyline Instruments Corporation" announced via press release on June 17, 2026. While the prose does not specify the investment amount, structure, or whether it constitutes a material acquisition under Item 1.01, a strategic investment by a public company is typically material to investors assessing the registrant's capital allocation and business strategy. The disclosure does not fit the more specific categories (ma_activity would require clearer language about acquisition/merger/change of control; dilutive_issuance would require equity issuance detail). Classified as other_material pending fuller details in the attached exhibit.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Fluent, Inc.'s 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents voting results for eight matters, including election of seven directors, say-on-pay advisory vote, auditor ratification, and approval of equity-related proposals. Shareholder vote results are material to investors as they confirm governance outcomes and approval of significant corporate actions such as equity plan amendments and warrant issuances.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-17
Item 5.02
The Compensation Committee approved and adopted the Senior Executive Annual Bonus Plan on June 15, 2026, establishing a compensatory arrangement for executive officers and designated employees. The plan specifies performance metrics, payment mechanisms (cash or stock under the 2022 Equity Incentive Plan), and clawback provisions. This is a material disclosure of a new compensation plan affecting executive officers, fitting squarely within the exec_compensation category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Twilio held its Annual Meeting of stockholders on June 16, 2026, with voting results disclosed on June 17, 2026. Five proposals were voted on and approved by substantial majorities: election of four Class I directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of amendments and restatements to the 2016 Stock Option and Incentive Plan and 2016 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-17
Item 8.01
The disclosure announces a Board declaration of an annual cash dividend of $0.55 per share with specific payment and record dates. While dividend declarations are routine corporate actions, this is material to shareholders as it affects their investment returns and the company's capital allocation. However, it does not fit neatly into the more specific event categories (not earnings, not executive-related, not M&A, not a restatement or going-concern issue), so "other_material" is the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from the June 12, 2026 Annual Meeting of Stockholders, covering three proposals: election of three Class I directors (Michael Singer, Timothy Springer, and Patrick Zenner), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-06-17
Mr. Steven Berman, the former Chief Executive Officer, resigned effective June 3, 2026, as part of a mutual settlement agreement resolving disputes arising from his suspension in May 2024 and an internal investigation into allegations against him. The departure of a CEO following a governance crisis and investigation is material to investors' assessment of the company's leadership and stability.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-06-17
Item 4.02
This is a clear restatement disclosure under Item 4.02. Management concluded on June 11, 2026 that previously issued condensed consolidated financial statements in two quarterly 10-Q filings should no longer be relied upon due to an error in the calculation of weighted-average shares outstanding used in EPS calculations. The error resulted in material overstatements and understatements of basic and diluted EPS across multiple periods (ranging from $0.08 to $4.26 per share), and the Company intends to file amended 10-Qs to restate the affected financial statements. This is a quintessential restatement event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Groupon held its 2026 Annual Meeting of Stockholders on June 11, 2026, with shareholders voting on four proposals: election of six directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of a certificate amendment for officer exculpation provisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This Item 5.07 disclosure reports the final voting results from Sabra Health Care REIT's annual meeting of stockholders held on June 17, 2026. The filing presents detailed voting tallies for three matters: election of seven directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. Shareholder vote results are material to investors as they confirm governance composition and audit oversight for the fiscal year.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-17
EX-99.2
The exhibit announces a 1-for-2 reverse stock split (share consolidation) effective June 25, 2026, approved by shareholders at the May 28, 2026 AGM. While a reverse split is technically a capital restructuring rather than a distribution, it materially affects share structure and is disclosed as a significant corporate action. The company cites Nasdaq listing-standard compliance and share-price support as rationales, indicating potential delisting risk if the split fails. This is material to investors assessing the registrant's compliance status and market position.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-17
MIRA Pharmaceuticals disclosed submission of a Phase 2a clinical trial protocol to the FDA for Ketamir-2, a proprietary oral NMDA receptor modulator for chemotherapy-induced peripheral neuropathy, with FDA acknowledgment of receipt. This represents a material clinical development milestone for a pharmaceutical company, but does not fit neatly into the standard taxonomy categories (not an earnings release, executive change, M&A activity, impairment, or other defined event types). The advancement of a lead drug candidate through FDA regulatory stages is material to investors assessing the company's pipeline and prospects.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-06-17
EX-99.1
J-Star received a Staff Delisting Determination Letter from Nasdaq on June 12, 2026, for failure to maintain the minimum bid price of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). The company is requesting a hearing before the Nasdaq Hearings Panel to appeal the determination and request additional time to regain compliance. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-17
The filing discloses the completion of a material acquisition of Cataneo GmbH for $19.5 million in aggregate consideration ($9 million cash plus 250,792 shares of common stock valued at $37.88 per share). Item 7.01 confirms all pre-closing obligations and conditions have been satisfied, and the Closing has occurred. This is a significant M&A transaction requiring disclosure under Item 1.01 (incorporated by reference to the April 30, 2026 8-K) and Item 3.02 (unregistered equity issuance as part of consideration).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses Item 5.07 results from the Company's June 12, 2026 Annual Stockholders' Meeting, including voting outcomes on seven proposals: election of seven directors, ratification of auditor (Wipfli LLP), approval of the 2026 Equity Incentive Plan, approval of convertible note issuance authority, amendment to increase authorized shares from 100M to 750M, advisory vote on executive compensation, and advisory vote frequency. These results are material to investors as they reflect shareholder approval of significant corporate actions including equity plan adoption and substantial share authorization increases.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-17
EX-99.1
Genius Group announced the cancellation of 26.6 million Class A Ordinary Shares (22% of public float) this week, comprising a 20-million-share return from ERL and a 6.6-million-share repurchase. While technically a share cancellation rather than a traditional dividend, this represents a return of capital to shareholders through reduction of issued share capital and is explicitly framed as part of the Company's capital allocation strategy to increase Net Asset Value per Share (NAVPS). The magnitude (22% of public float) and strategic intent make this material to investors assessing shareholder value.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
SharonAI Holdings entered into Securities Purchase Agreements on June 17, 2026 for a private offering of approximately 6.7 million shares of Class A ordinary common stock at $68.73 per share, pre-funded warrants, and $600 million of 4.75% Convertible Senior Notes due 2032, generating approximately $1.5 billion in aggregate gross proceeds. The convertible notes are convertible into up to approximately 13.1 million shares of Common Stock at an initial conversion price of $95.66 per share. This is a material dilutive equity issuance raising substantial capital for the company's NVIDIA compute collaboration and AI Factory expansion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-17
Liberty Star entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC to issue a $73,700 convertible promissory note with 10% Original Issue Discount, convertible into common stock. This is a dilutive issuance of equity securities (via conversion rights embedded in the convertible note), a material financing event for a small-cap uranium exploration company that signals capital-raising pressure and future shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-17
Item 1.02
XCF Global terminated a $50 million equity purchase agreement with Helena Global Investment Opportunities I LTD. that had reserved approximately 55 million shares for potential issuance. While the termination itself eliminates dilution risk, the core event disclosed is the unwinding of a dilutive equity arrangement that previously posed material overhang and dilution concerns. The filing emphasizes the reduction in "potential dilution and associated market overhang," indicating this was a material equity issuance arrangement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses results of the Company's 2026 Annual Meeting of Shareholders held on June 11, 2026, with voting outcomes on four proposals: election of four directors, ratification of the independent auditor (CBIZ CPAs P.C.), advisory approval of named executive officer compensation, and approval of an amendment to the Equity Incentive Plan increasing authorized shares by 1,750,000. Item 5.07 explicitly presents detailed voting tallies for each proposal, which is the core disclosure required for shareholder vote results under the 8-K taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The 8-K discloses results of Biofrontera's Annual Meeting of Stockholders held on June 11, 2026, under Item 5.07. The filing reports three matters voted on: election of two Class II directors (Beth J. Hoffman, Ph.D. and Kevin D. Weber), approval of an amendment to the 2021 Omnibus Incentive Plan increasing authorized shares from 3.75M to 8.75M, and ratification of CBIZ CPAs P.C. as independent auditor. These are routine but material shareholder votes affecting governance and equity authorization.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-17
Item 5.02
Karen Hawkins, Chief Financial Officer and Secretary of Optex Systems Holdings, Inc., notified the Company on June 12, 2026 of her intention to resign effective December 31, 2026. The departure of a CFO is a material executive change that would affect a reasonable investor's assessment of the registrant's financial leadership and continuity. The filing explicitly states no disagreements or accounting issues were involved, confirming this is a straightforward departure disclosure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-06-17
The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses Item 5.07 results from Hepion Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three proposals: election of five directors (Gary Stetz, Vincent LoPriore, Michael Purcell, Sireesh Appajosyula, and Chase LoPriore), ratification of Grassi & Co. as independent auditors, and approval of an amendment to the 2023 Omnibus Equity Incentive Plan to increase authorized shares to 8,000,000. These shareholder votes are material to investors as they determine board composition and equity plan capacity.
View raw filing on EDGAR →